Back
Phathom Pharmaceuticals Vs. Oramed Pharmaceuticals Industry Stock Comparison
Buy
69
PHAT
Phathom Pharmaceuticals
Last Price:
$10.65
Seasonality Move:
13.25%
Sell
19
ORMP
Oramed Pharmaceuticals
Last Price:
$2.17
Seasonality Move:
0.24%
Buy
69
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
-
The current Phathom Pharmaceuticals [PHAT] share price is $10.64. The Score for PHAT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
-
The current Oramed Pharmaceuticals [ORMP] share price is $2.12. The Score for ORMP is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
ORMP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.54 | Buy |
Relative Strength Index (14 RSI): | 86.4 | Buy |
Chaikin Money Flow: | 532694 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ORMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 41.73 | Sell |
Chaikin Money Flow: | -42954 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.23 | Buy |
20-day SMA: | 5.86 | Buy |
50-day SMA: | 4.65 | Buy |
200-day SMA: | 9.2 | Buy |
8-day EMA: | 8.53 | Buy |
20-day EMA: | 6.6 | Buy |
50-day EMA: | 5.48 | Buy |
200-day EMA: | 7.49 | Buy |
ORMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.21 | Sell |
20-day SMA: | 2.2 | Sell |
50-day SMA: | 2.22 | Sell |
200-day SMA: | 2.32 | Sell |
8-day EMA: | 2.21 | Sell |
20-day EMA: | 2.22 | Sell |
50-day EMA: | 2.23 | Sell |
200-day EMA: | 2.33 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.92 per share, an increase next quarter of $0.37 per share, an increase this year of $1.80 per share, and an increase next year of $2.44 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oramed Pharmaceuticals Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |